Alert icon

To align with industry best practices for security and data integrity, Project Data Sphere is requiring users to upgrade their browsers to one that supports encryption protocol TLS 1.2 by December 15, 2017. On that date, Project Data Sphere will disable support of browsers that permit SSL 3.0/TLS 1.0. To prevent any disruption to your access to Project Data Sphere, you must take action.
This browser was not recognized and may not be compatible with TLS 1.2 or higher. Please check with the browser's developer to confirm.
To view information about this, please visit the FAQ. If you have any further questions, please contact us.

Back to the List
Type(s) of Cancer
Leukemia
Study Phase
Phase 3
Study Completion Date
August 2013
NCT00372593Uploaded 03-24-2021
Access via NCI by Request
PDS UID: nci-data-460
A Phase III Randomized Trial of Gemtuzumab Ozogamicin (Mylotarg) Combined With Conventional Chemotherapy for De Novo Acute Myeloid Leukemia (AML) in Children, Adolescents, and Young Adults
Files: NCT00372593-D3
Data DictionaryNCT00372593-D3-Data-Dictionary_2.pdf
DATANCT00372593-D3-Dataset_2.csv
OTHERREADME.pdf